STING ligand–receptor interactions occur in various immune cells within the tumor microenvironment, including dendritic cells, macrophages, T cells, and B cells, mediating the secretion of antitumor cytokines and chemokines such as IL-18 and CXCL10 [21,22,23,24]. The gene discussed is STING1; the disease is neoplasm.